Diabetes During Pregnancy Associated With Increased Risk of Low Milk Supply
CINCINNATI--A new study shows that women with diabetes during pregnancy face a significantly higher risk of having a low milk supply.
The Cincinnati Children's Hospital Medical Center study, published online in Breastfeeding Medicine, adds to evidence that maternal glucose intolerance may impede lactation. Although insulin resistance is common among obese women, and obesity is a risk factor for poor lactation outcomes, the study is believed to be the first to examine maternal diabetes as a risk factor for low milk supply.
"This study shows the importance of further research to determine how maternal glucose intolerance may impede lactation, so that targeted therapies may be developed to increase milk supply," says Sarah Riddle, MD, a pediatrician in the Center for Breastfeeding Medicine at Cincinnati Children's, an assistant professor of pediatrics at the University of Cincinnati College of Medicine and the study's lead author. "There are limited evidence-based strategies for helping mothers to increase milk supply, and low milk supply is often cited as the reason for new mothers to stop breastfeeding earlier than planned."
The study was conducted using existing electronic medical records of 641 women who made first visits to the Center for Breastfeeding Medicine between June 1, 2011, and May 31, 2013. All women were no more than 90 days postpartum and highly motivated to breastfeed.
Mothers with a diagnosis of low milk supply but no other lactation problems, such as latching onto the breast, were compared to mothers with lactation problems but without low milk supply. Nearly 15 percent of those in the first group had a history of diabetes during pregnancy, while just over 6 percent with lactation problems but not low milk supply had maternal diabetes.
The study was funded by a grant to senior author Laurie Nommsen-Rivers, PhD, a scientist in the Cincinnati Children's Research Foundation and UC assistant research professor of pediatrics, from the National Institutes of Health Office of Research on Women's Health (5 K12 HD0511953).
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.